GL
Geulah Livshits Chardan Capital Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
84
Avg Return
Past Year
Past Year
22%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
100%
Neutral
0%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $27 |
105%
upside
| 2 | +21% |
0
%
| 2 Mar ‘26 3 days ago |
|
|
|
Buy
Maintained
| $210 |
56%
upside
| 2 | +36% |
0
%
| 24 Feb ‘26 9 days ago |
|
|
|
Buy
Maintained
| $323 |
24%
upside
| 1 | +13% |
0
%
| 18 Feb ‘26 16 days ago |
|
|
|
Buy
Maintained
| $76 |
33%
upside
| 1 | +13% |
0
%
| 17 Feb ‘26 17 days ago |
|
|
|
Buy
Maintained
| $17 |
151%
upside
| 2 | +15% |
0
%
| 13 Jan ‘26 1 month ago |
|
|
|
Buy
Maintained
| $12 |
167%
upside
| 1 | +18% |
0
%
| 6 Jan ‘26 1 month ago |
|
|
|
Buy
Maintained
| $26 |
201%
upside
| 1 | +21% |
0
%
| 18 Dec ‘25 2 months ago |
|
|
|
Buy
Maintained
| $8 |
876%
upside
| 1 | +18% |
0
%
| 12 Dec ‘25 2 months ago |
|
|
|
Buy
Maintained
| $13 |
1,286%
upside
| 1 | -16% |
0
%
| 9 Dec ‘25 2 months ago |
|